Explore

Trendline Trendline
Blank Bio Secures Funding and Partners with PacBio for RNA Oncology Models

Blank Bio Secures Funding and Partners with PacBio for RNA Oncology Models

Blank Bio Secures Funding and Partners with PacBio for RNA Oncology Models
Trendline Trendline
Blank Bio Secures Seed Financing and Partners with PacBio to Enhance Precision Oncology

Blank Bio Secures Seed Financing and Partners with PacBio to Enhance Precision Oncology

Blank Bio Secures Seed Financing and Partners with PacBio to Enhance Precision Oncology
Trendline Trendline
Daiichi Sankyo Faces Challenges in Antibody-Drug Conjugate Market Amid Setbacks

Daiichi Sankyo Faces Challenges in Antibody-Drug Conjugate Market Amid Setbacks

Daiichi Sankyo Faces Challenges in Antibody-Drug Conjugate Market Amid Setbacks
Trendline Trendline
BioMarin Faces Setback with Phase 3 Trial Failure in Rare Disease Treatment

BioMarin Faces Setback with Phase 3 Trial Failure in Rare Disease Treatment

BioMarin Faces Setback with Phase 3 Trial Failure in Rare Disease Treatment
Trendline Trendline
OpenBind Launches AI Model for Drug Discovery with Extensive Dataset

OpenBind Launches AI Model for Drug Discovery with Extensive Dataset

OpenBind Launches AI Model for Drug Discovery with Extensive Dataset
Trendline Trendline
Shyld AI Secures $13.4 Million to Expand Active AI in U.S. Hospitals

Shyld AI Secures $13.4 Million to Expand Active AI in U.S. Hospitals

Shyld AI Secures $13.4 Million to Expand Active AI in U.S. Hospitals
Trendline Trendline
OpenBind Consortium Launches AI Model to Revolutionize Drug Discovery

OpenBind Consortium Launches AI Model to Revolutionize Drug Discovery

OpenBind Consortium Launches AI Model to Revolutionize Drug Discovery
Trendline Trendline
MSD's Sac-TMT Shows Promise in Phase 3 Endometrial Cancer Trial

MSD's Sac-TMT Shows Promise in Phase 3 Endometrial Cancer Trial

MSD's Sac-TMT Shows Promise in Phase 3 Endometrial Cancer Trial
Trendline Trendline
Tiziana Life Sciences Reports Positive Data for Intranasal Foralumab in Multiple Sclerosis Patients

Tiziana Life Sciences Reports Positive Data for Intranasal Foralumab in Multiple Sclerosis Patients

Tiziana Life Sciences Reports Positive Data for Intranasal Foralumab in Multiple Sclerosis Patients
Trendline Trendline
Stilta Secures $10.5M Funding to Revolutionize Patent Discovery with AI

Stilta Secures $10.5M Funding to Revolutionize Patent Discovery with AI

Stilta Secures $10.5M Funding to Revolutionize Patent Discovery with AI
Trendline Trendline
Sino Biological Launches XPressMAX™ Kit to Enhance Antibody Drug Discovery

Sino Biological Launches XPressMAX™ Kit to Enhance Antibody Drug Discovery

Sino Biological Launches XPressMAX™ Kit to Enhance Antibody Drug Discovery
Trendline Trendline
Aspera Biomedicines Launches Second ADAR1p150 Experiment to ISS

Aspera Biomedicines Launches Second ADAR1p150 Experiment to ISS

Aspera Biomedicines Launches Second ADAR1p150 Experiment to ISS